REGiMMUNE Presents Enhanced Efficacy Data in Preclinical Transplantation Models at the 2009 American Transplant Congress
June 01, 2009 08:00 ET
|
REGiMMUNE
BOSTON, MA--(Marketwire - June 1, 2009) - REGiMMUNE Corporation today announced that its
lead product candidate RGI-2001, in combination with a low-dose of
Sirolimus, demonstrated enhanced efficacy...
REGiMMUNE to Present at the 2009 American Transplant Congress
May 12, 2009 07:58 ET
|
REGiMMUNE
MOUNTAIN VIEW, CA--(Marketwire - May 12, 2009) - REGiMMUNE Corporation today announced
that a company abstract has been accepted for presentation at the 2009
American Transplant Congress (ATC, May 30...
REGiMMUNE Receives $12 Million in Grants to Develop Transplant and Allergy Drugs
December 08, 2008 08:00 ET
|
REGiMMUNE
MOUNTAIN VIEW, CA and TOKYO--(Marketwire - December 8, 2008) - REGiMMUNE Corporation, a
privately held biopharmaceutical company focused on developing technologies
and products for immune disorders,...
REGiMMUNE Raises $8,000,000 in Series B Financing
May 06, 2008 08:00 ET
|
REGiMMUNE
MOUNTAIN VIEW, CA and TOKYO--(Marketwire - May 6, 2008) - REGiMMUNE Corporation, a
privately held biopharmaceutical company, announced today that it has
closed its Series B financing for a total of...
REGiMMUNE Receives Grant Award From METI
August 08, 2007 08:00 ET
|
REGiMMUNE
MOUNTAIN VIEW, CA and TOKYO, JAPAN--(Marketwire - August 8, 2007) - REGiMMUNE Corporation, a
privately held biopharmaceutical company, announced today it has been
awarded a grant from the Japanese...
REGiMMUNE Announces Appointment of Shirley Clayton to Board of Directors
February 21, 2007 08:30 ET
|
REGiMMUNE
MOUNTAIN VIEW, CA and TOKYO -- (MARKET WIRE) -- February 21, 2007 -- REGiMMUNE Corporation., a
privately held biopharmaceutical company, announced today the appointment
of Shirley Liu Clayton as a...
REGiMMUNE Announces Series B Financing
February 21, 2007 08:00 ET
|
REGiMMUNE
MOUNTAIN VIEW, CA and TOKYO -- (MARKET WIRE) -- February 21, 2007 -- REGiMMUNE Corporation., a
privately held biopharmaceutical company, announced today that it has
raised $4.2 million U.S. in a...